BRIEF published on 09/16/2025 at 18:05, 7 months 16 days ago ABIVAX: Distribution of Share Capital and Voting Rights Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF published on 09/16/2025 at 10:04, 7 months 17 days ago JP Morgan Chase exceeds 5% threshold in ABIVAX Capital Actions Abivax Threshold Crossing JP Morgan Chase
BRIEF published on 09/12/2025 at 17:50, 7 months 21 days ago Abivax Joins CAC Mid 60 and SBF 120 Indices Euronext Paris Biotechnology Abivax SBF 120 CAC Mid 60
PRESS RELEASE published on 09/12/2025 at 17:45, 7 months 21 days ago Abivax to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review Abivax to join CAC Mid 60 and SBF 120 Indices on Euronext Paris following annual review, enhancing visibility and investor base Euronext Paris Abivax SBF 120 Index Inclusion CAC Mid 60
BRIEF published on 09/08/2025 at 22:05, 7 months 24 days ago Abivax Reports First Half 2025 Financial Performance Financial Results Research And Development Convertible Notes Public Offering Cash Reserves
PRESS RELEASE published on 09/08/2025 at 22:00, 7 months 24 days ago Abivax Presents First Half 2025 Financial Results Abivax presents first half 2025 financial results, revealing operating loss increase and net loss for the period, also updates on clinical programs and public offering Financial Results Abivax Public Offering Clinical Programs Operating Loss
BRIEF published on 09/02/2025 at 11:00, 8 months 1 day ago JP Morgan Chase & Co. Crosses Threshold at ABIVAX Voting Rights Capital Abivax Threshold Crossing JP Morgan
BRIEF published on 08/13/2025 at 18:05, 8 months 20 days ago ABIVAX: Update on capital and voting rights Euronext Paris Share Capital Voting Rights AMF Abivax
BRIEF published on 08/13/2025 at 18:05, 8 months 20 days ago ABIVAX: Share and voting rights data as of July 31, 2025 Euronext Paris Voting Rights Biotechnology Actions AMF Regulations
BRIEF published on 07/28/2025 at 22:20, 9 months 5 days ago Abivax Completes $747.5 Million Public Offering Biotechnology Abivax Ulcerative Colitis Nasdaq Public Offer
Published on 05/02/2026 at 21:00, 21 hours ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 16 hours ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 17 hours ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 18 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 18 hours ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/03/2026 at 04:45, 13 hours 15 minutes ago GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 1 day 2 hours ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 22 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/30/2026 at 20:00, 2 days 22 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 2 days 22 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 2 days 23 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 2 days 23 hours ago Minutes of the Combined General Meeting held on April 30, 2026
